TABLE 2.

Patient characteristics.

Variables		Number (%)
Age (years)	10–19	17 (1.09%)
	20–29	289 (18.53%)
	30–39	384 (24.62%)
	40–49	365 (23.40%)
	50–59	309 (19.81%)
	60–69	159 (10.19%)
	70–79	35 (2.24%)
	80–89	2 (0.13%)
Sex	Male	563 (36.09%)
	Female	997 (63.91%)
Eye pain	Yes	1,278 (81.92%)
	No	282 (18.08%)
Visual loss	Yes	334 (21.41%)
	No	1,226 (78.59%)
Diplopia	No	896 (57.44%)
	Vertical	59 (3.78%)
	Horizontal	12 (0.77%)
	Mixed	593 (38.01%)
Eyelid retraction	Yes/no	479 (30.71%)/1,081 (69.29%)
Eyelid congestion	Yes/no	236 (15.13%)/1,324 (84.87%)
Eyelid edema	Yes/no	870 (55.77%)/690 (44.23%)
Lid lag	Yes/no	388 (24.87%)/1,172 (75.13%)
Lacrimal caruncle edema	Yes/no	24 (1.54%)/1,536 (98.46%)
Eye movement disorders	Yes/no	1,209 (77.50%)/351 (22.50%)
Conjunctival congestion	Yes/no	977 (62.63%)/583 (37.37%)
Chemosis	Yes/no	1,084 (69.49%)/476 (30.51%)
Corneal ulcer	Yes/no	116 (7.44%)/1,444 (92.56%)
Type of TAO	Hyperreflexive	1,324 (84.87%)
	Normal	193 (12.37%)
	Hyporeflexive	43 (2.76%)
Stage of TAO	Active	487 (31.22%)
	Quiescent	1,073 (68.78%)
Grade of TAO	Mild	89 (5.71%)
	Moderately severe	1,290 (82.69%)
	Very severe	181 (11.60%)

TAO, thyroid-associated ophthalmopathy.